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Abstract. Animal venoms and toxins are a valuable source of bioactive peptides with
pharmacologic relevance as potential drug leads. A large subset of biologically active
peptides discovered up till now contain disulfide bridges that enhance stability and
activity. To discover newmembers of this class of peptides, we developed a workflow
screening specifically for those peptides that contain inter- and intra-molecular disul-
fide bonds by means of three-dimensional (3D) mass mapping. Two intrinsic proper-
ties of the sulfur atom, (1) its relatively large negative mass defect, and (2) its isotopic
composition, allow for differentiation between cysteine-containing peptides and pep-
tides lacking sulfur. High sulfur content in a peptide decreases the normalized
nominal mass defect (NMD) and increases the normalized isotopic shift (NIS). Hence
in a 3D plot of mass, NIS, and NMD, peptides with sulfur appear in this plot with a distinct spatial localization
compared with peptides that lack sulfur. In this study we investigated the skin secretion of two frog species;
Odorrana schmackeri and Bombina variegata. Peptides from the crude skin secretions were separated by
nanoflow LC, and of all eluting peptides high resolution zoom scans were acquired in order to accurately
determine both monoisotopic mass and average mass. Both the NMD and the NIS were calculated from the
experimental data using an in-house developed MATLAB script. Candidate peptides exhibiting a low NMD and
high NIS values were selected for targeted de novo sequencing, and this resulted in the identification of several
novel inter- and intra-molecular disulfide bond containing peptides.
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Introduction
The venoms and toxins of animals are a major source ofbiologically active peptides and currently over 5000 of
these peptides are recorded in the UniProt protein database
[1, 2]. The nature of activity ranges from antimicrobial to
neurotoxic, and this specific collection of peptides has proven
to be an excellent source of potential new drug leads [3–5]. The
classical route for the discovery of a bioactive peptide conven-
tionally starts with determination of biological activity of the
whole crude venom. Identification of individual peptides that
are responsible for a certain activity is only achieved after
extensive purification. Subsequent primary structure character-
ization either involves (de novo) sequencing via Edman deg-
radation or tandem mass spectrometry (MSn). Cloning of mes-
senger RNA encoding the bioactive peptides is another pow-
erful approach [6], but only possible if some information of the
primary sequence is known upfront.
Currently, the most widely used tool to study mixtures of
non-tryptic endogenous peptides involves de novo sequencing
from high resolution MSn experiments using the ‘shotgun’
approach [7]. Characterization of animal toxin peptides via this
approach is generally complicated because of the high number
and high variety of post-translational modifications (PTMs),
which makes de novo sequencing a difficult and time-
consuming task [8, 9]. Fragmentation spectra can be ‘manually’
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interpreted or analyzed using specialized algorithms for auto-
mated de novo sequencing such as PEAKS (Bioinformatics
Solutions Inc., Waterloo, ON, Canada), PepNovo [10], and
pNovo+ [11]. Full structure elucidation is only possible when
complete fragmentation occurs and the spectrum is of sufficient
quality with respect to signal-to-noise ratio. Instrumental pa-
rameters often need to be optimized for every peptide individ-
ually to yield spectra that meet these standards. Owing to the
fact that a toxin sample can contain dozens of different peptides
with accompanying truncated or partially degraded products,
manually acquiring optimized tandem MS spectra for each
individual peptide species and interpreting all their fragmenta-
tion spectra is a tremendously labor-intensive task. It is desirable
to have several selection criteria to specifically target those
peptides that meet these criteria upfront, before engaging in
the time consuming task of de novo sequencing.
Remarkably, many of the biologically active peptides contain
one or multiple disulfide bridges, which are believed to contribute
to the peptides’ stability and activity. This is illustrated by the high
prevalence of cysteines (6.91% of all residues) in the reviewed
database from the animal toxin annotation program at UniProt
compared with the whole UniProtKB/Swiss-Prot (release 2015_1)
database (1.37% of all residues). The presence of disulfide bonds
could thus be used as a selection criterion to target for unknown
peptides in animal toxins and venoms with bioactivity potential.
A conventional way of determining the presence of disulfide
bonds in a peptide is by simply counting the mass shift before and
after reduction [12] or after reduction and alkylation [13].
Disadvantages of this approach are that it requires comparison of
two separate analyses and that it is difficult to detect dimeric
peptides in complex mixtures. Prior to sequence analysis of pep-
tides, disulfide bonds are often reduced to improve the quality of
MS2 spectra [14]. Additionally, free thiol groups of the cysteines
can be derivatized using specific reagents such as iodoacetamide
or selenamide [15, 16]. Themain advantages of this type of sample
preparation are that disulfide bridges cannot randomly reform and
fragmentation of themodified peptide could yield higher sequence
coverage [15, 16]. An additional advantage is that the derivatizing
group could be engineered in such a way that cysteine-containing
peptides can be specifically detected using tandem mass tags
(TMT) [17, 18] in MS or even purified using isotope-coded
affinity tags (iCAT) [19]. A disadvantage is that these labels are
often relatively large and will negatively influence fragmentation,
making de novo sequencing evenmore difficult. Specific isolation,
such as in the case of iCAT, requires substantial amounts of
starting material, which is not easy to obtain in the case of animal
venoms.Another disadvantagewith these labeling strategies is that
it requires reduction of the disulfide bonds and, thereby, secondary
structure information of dimeric peptides is lost.
In order to quickly assign the presence of cysteines in a
peptide of unknown nature without the need of reduction of
disulfide bond, we propose here to use a high resolution mass
filtering approach. Two intrinsic characteristics of the sulfur atom
can be used to select peptides with cysteine residues. Sulfur has a
relatively large negative mass defect (the difference between the
isotopic and nominal or integer mass) and it has a positive
isotopic shift (difference between average and monoisotopic
mass) [20]. Normalization of these two shifts results in two
non-additive and independent peptide properties, which were
previously introduced as normalized nominal mass defect
(NMD) and normalized isotopic shift (NIS) by Artemenko et al.
[21]. Certain types of peptides are localized in distinct regions on
a 2D plot of NMD versus NIS, due to different chemical com-
position. For example, NMD tends to increase due to very basic
(arginine, lysine) and aliphatic (leucine, isoleucine, valine) amino
acids, but decreases in the presence of acidic (aspartic acid and
glutamic acid) or sulfur-containing (cysteine and methionine)
residues. Furthermore, it was shown that different families of
peptides can be distinguished from the 2D plot [21]. It should
be noted here that although this is an elegant approach, it has so
only been used as a data representation method after de novo
sequencing [21].With the advent of modern high resolution (HR)
mass spectrometry devices, it now becomes possible to use mass
defect filtering of unknown peptides in complex samples.
In this study, we expand the mass mapping approach to select
for cysteine-containing peptides prior to de novo sequencing,
based on NMD, NIS, and overall mass. Although it is common
practice to determine the monoisotopic mass of a peptide with
high precision usingmodern high resolutionmass spectrometers,
the average mass is not a directly measurable value. The average
mass can be calculated from the ion abundance of all detected
isotopomers.We developed a data-dependent analysis workflow
to experimentally determine the monoisotopic and average
masses of unknown peptides, in order to calculate NIS and
NMD values. By making a three-dimensional (3D) plot of
NMD, NIS, and monoisotopic mass, peptides containing sulfur
are differentiated from non-sulfur containing peptides, and those
can then be further targeted for extensive MSn based analysis
and full primary structure elucidation. We demonstrate this
workflow via the analysis of peptides in the secretions produced
by the granular skin glands of two anuran amphibian species,
Odorrana schmackeri and Bombina variegata.
Experimental
Granular Gland Skin Secretions
Skin secretion of Odorrana schmackeri and Bombina variegata
were a kind gift from Professor Chris Shaw, Queen’s University,
Belfast, UK. The crude lyophilized skin secretions (~100 μg)
were resuspended in 100 μL of 50 mM ammonium bicarbonate
containing 1 M urea and 25% acetonitrile. Insoluble material
was removed by centrifugation at 17,800 relative centrifugal
force (RCF) for 15 min. The supernatant was split in two parts;
one part was directly measured by LC-MS and the other part was
treated with 20 mM tris(2-carboxyethyl)phosphine (TCEP;
Sigma-Aldrich, Munich, Germany) to reduce disulfide bonds.
LC-MS
Samples were analyzed by on-line nanoflow LC-MS using an
Agilent 1200 HPLC system and a LTQ-Orbitrap Velos
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(ThermoFisher Scientific, Bremen, Germany) mass spectrom-
eter. Samples were injected onto an in-house made trap column
with dimensions 20mmL × 100 μm i.d., filled with particles of
5 μm diameter (Reprosil Pur C4; Dr. Maisch GmbH,
Ammerbuch-Entringen, Germany). After trapping, the peptides
were separated on an in-house made analytical column (C4,
dimensions 140 mm L × 75 μm i.d., 5 μm particle size). The
vented column setup was adjusted to an analytical column flow
rate of 150–200 nL/min, solvent A was 0.6% acetic acid in
Milli-Q, solvent B was 0.6% acetic acid in 80% acetonitrile in
Milli-Q (v/v). The effluent of the column was directly sprayed
into the ion source of the LTQ-Orbitrap Velos mass spectrom-
eter. For determination of the monoisotopic and average mass,
the most abundant multiply charged ions were automatically
selected for HR zoom scans. Full Fourier transform MS scan
width was set to the range 400–1500m/z in profile mode with a
resolution of 30,000 at 400 m/z. Multiply charged ions with a
minimal intensity of 2 × 105 were selected for a zoom scan with
a resolution of 30,000 at 400 m/z, acquired in centroid mode
with an isolation width set from –1.50 to +2.25 Dalton (Da)
with respect to the selected precursorm/z value. For each zoom
scan four microscans (AGC target value set to 1 × 105, maxi-
mal injection time set to 500 ms) were combined. For the
acquisition of HCD peptide fragmentation spectra, a second
data-dependent analysis was performed. Fragmentation spectra
were acquired at a resolution of 30,000 atm/z 400 starting with
a fixed first mass atm/z 100. For each precursor, three separate
HCD spectra were acquired at normalized HCD energy of 26,
28, and 30. The isolation window was set to 2.5 m/z, signal
threshold for selection was 1 × 105, AGC target was 5 × 105,
and maximum injection time was set to 200 ms.
3D Mass Mapping
The Xcalibur (ThermoFischer) *.raw files were converted to
*.mzXML files using the ReAdW software (ver. 2.0, available
at http://sourceforge.net/projects/sashimi/files/) and *.mzXML
files were subsequently imported into the in-house developed
MATLAB script (MATLAB and Bioinformatics Toolbox, re-
lease 2014a, The MathWorks, Inc., Natick, MA, USA). This
script determines from each zoom scan spectrum the charge of
the ion and calculates its monoisotopic mass. The average mass
of each peptide is calculated from the peak height (ion intensi-
ty) and corresponding m/z values of all observed isotopomers
above 3% in a zoom scan. This MATLAB script is available as
Supplementary Material (Script-I).
For the determination of theoretical NMD and NIS values of
all reviewed peptide/protein sequences from the animal venom
and toxin annotation program [1, 2], all sequences smaller than
35 amino acids were downloaded in FASTA format, which
allowed for direct import into MATLAB. From the primary
amino acid sequence, the elemental composition was deter-
mined. Using this theoretical monoisotopic mass, nominal
mass and average mass were calculated. The experimental
nominal mass was calculated using Equation 1, and NIS and
NMD values were calculated using Equations 2 and 3,
respectively. For a reference see Artemenko et al. [21]. This
MATLAB script is available as Supplementary Material
(Script-II).
Nominalmass ¼ integer 0:9995monoisotopicmassð Þ ð1Þ
NIS ¼ 1000 averagemass –monoisotopicmassð Þ=monoisotopicmass
ð2Þ
NMD ¼ 1000 monoisotopicmass – nominalmassð Þ=monoisotopicmass
ð3Þ
Database Searching
Database searching of HCD fragmentation spectra acquired
from both O. schmackeri and B. variegata was done using
MASCOT (MASCOT server 2.2, Matrixscience Inc,
Boston, MA, USA) against the UniProt entries anura (Tax
ID 8342): protein and peptides sequences with 35 amino
acids or less (downloaded in January 2015). The search
parameters were set to the following; no enzyme, 5 ppm
parent tolerance, 0.02 Da fragment tolerance, no enzyme
specificity. C-terminal amidation was included as variable
modification. De novo sequencing of selected peptides was
done by combining information obtained by manual inter-
pretation of the fragmentation spectra from different charge
states of the peptide.
Results and Discussion
Disulfide bridges are a common PTM encountered in animal
toxin and venom peptides. To illustrate this, over 85% of all
reviewed peptides in the UniProt Toxin and Venom database
[1, 2] contain at least one disulfide bond. For all these peptide
sequences up to 35 amino acids (a total of 1050 sequences), the
mass, NIS and NMD were calculated (using Supplementary
Information, Script-II) and plotted (Figure 1) using and a color
code to differentiate the number of cysteines. A general trend is
observed in which peptides with a molecular weight between
1000 and 2000 Da and no cysteines have low NIS (0.55–0.65)
and high NMD values (0.50–0.75) (Figure 1a and d). Peptides
with one or more cysteines shift to higher NIS and lower NMD
values (Figure 1b), which is accompanied by increasing mo-
lecular weight. Based on the number of cysteines, distinct
clusters can be discerned in the 3D plot in Figure 1. Using such
a 3D mass map, threshold values for both NMD and NIS were
inferred that can be used to select peptides for de novo
sequencing.
Figure 1b–d illustrate the general trend that peptides with a
NMD below 0.55, and a NIS higher than 0.65 are likely to
contain cysteine residues. For some peptides with a high
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number of cysteines, NIS values can exceed 0.8 and NMD can
even decrease to below 0.35. It should be noted here that
besides cysteines, methionine residues contain a sulfur atom
as well. Upon investigation of the amount of methionine resi-
dues present in this collection of sequences, it was established
that peptides containing solely methionine as sulfur source also
have a distinct localization in the plot, which differs from the
cysteine-containing peptides (Supplementary Information,
Figure I). This could due to the nature of the peptide (i.e.,
belonging to specific peptide families) or due to the fact that
most methionine-containing peptides have only a single methi-
onine-residue, whereas cysteine-containing peptides typically
have multiple cysteine residues. As demonstrated for this col-
lection of venom and toxin peptides, 3D mass mapping allows
for filtering of cysteine-containing peptides from non-cysteine-
containing peptides, even in cases where the latter contain a
methionine residue. Our experimental determination of NMD
and NIS values of unknown peptides is based on high resolu-
tion MS and zoom-scans. Determination of NIS and NMD
values directly from the survey full scan MS spectrum would
require a further advanced algorithm combining isotopic peak
pattern and peak shape recognition. The use of a data-
dependent MS2 based strategy based on zoom-scans works
with much less complicated data processing.
The skin secretion of Odorrana schmackeri is relatively
well characterized and so far the primary structures of 27
peptides are listed in the UniProt protein database. The
majority (25) of them have a C-terminal disulfide bond,
often referred to as ‘Rana-box’ [22]. Skin secretion of
O. schmackeri was reduced with TCEP and separated by
nano-HPLC during a 120 min analysis. The base peak
intensity chromatogram is depicted in Figure 2a. The MS
system was programmed to acquire full scan spectra from
m/z 400 to 1500. For each eluting multiply charged peptide
exceeding the preset ion intensity threshold, a high resolu-
tion zoom-scan was acquired. A zoom-scan is the acquisi-
tion of the ion in a small m/z window that is written as a
separate scan event in the raw data file. To avoid spectral
contamination by other ions, an optimized zoom-scan win-
dow of –1.50 to +2.25 Da was used. Within the mass range of
all peptides analyzed in this study and the multiple charging
nature of electrospray ionization, all isotopomers above 1%–2%
of a single peptide are visible within this window. The *.raw











































































Figure 1. (a) Three-dimensional plot of NMD versus NIS versusmonoisotopicmass (Da) of peptides smaller than 35 amino acids in
UniProt animal venom and toxin database. Inset in (a) shows color scale used to label amount of cysteine residues in a sequence. (b)
Two-dimensional plot (side view) of peptide mass versus NMD. (c) Side view of NIS versus NMD. (d) Side view of peptide mass
versus NIS
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imported into MATLAB, where all zoom scans were converted
into a MATLAB structure. A script was programmed to process
all zoom scans for calculation of both average and monoisotopic
mass (Supplementary Information, Script-I).
The processing consists of several steps. First, all zoom
scans of poor quality indicated by a low total ion count are
discarded. For all remaining zoom scans, noise peaks are re-
moved by discarding all intensity peaks below 3% of the most
abundant peak. Using the remaining peaks, the charge state is
determined, followed by calculation of average and monoiso-
topic mass. As an example, the most abundant peptide in the
O. schmackeri skin secretion eluting at 68 min was selected.
This peptide was identified as Odorranain-C7HSa (UniProt
accession: B4ERK5_ODOSH) with amino acid sequence
SLLGTVKDLLIGAGKSAAQSVLKGLSCKLSKDC, and
Figure 2b shows the data-dependent zoom scan of the [M +
4H]4+. From the abundance of all isotopomers, the calculated
NMD and NIS values are 0.56 and 0.62, respectively. These
values are close to the theoretical values of 0.55 and 0.63, as
calculated based on the chemical composition derived from the
amino acid sequence.
To determine the accuracy of our workflow, a separate
measurement was performed in which high resolution HCD
fragmentation spectra were acquired. A MASCOT database
search was performed against anura protein entries listed in
the UniProt database (search results are provided in
Supplementary Information, Table 1). A total of 35 protein
identifications were made using 182 peptide spectral
matches. Using the identified peptides, theoretical NIS and
NMD values were calculated and compared with the exper-
imental determined values. For a total of 104 peptides, we
compared experimental monoisotopic mass and average
mass with the theoretically calculated values (results are
provided in Supplementary Information, Table 2). From this
comparison, the error between experimental and theoretical
monoisotopic mass and average mass were –0.73 and
+26.2 ppm, respectively (see Figure 2c), indicating that
our computation of average mass and subsequent calcula-
tion of NIS and NMD values are relatively accurate.
Figure 2d and e show, respectively, the 3D plot of mass,
NMD, and NIS and the 2D plot of NMD and NIS values for
O. schmackeri. The majority of detected peptides have
NMD values in the range of 0.45 to 0.50 and have NIS
values in the range of 0.60 to 0.70, indicating a high pro-
portion of disulfide bond containing peptides in this spe-
cies’ skin secretion. This is also in agreement with the high
number of disulfide bonds containing peptides identified in
previous studies.
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Figure 2. (a) Base peak intensity chromatogram of nanoflow HPLC-MS analysis of skin secretion of Odorrana schmackeri. (b)
Zoom scan of [M + 4H]4+ of peptide Odorranain-C7HSa (UniProt accession: B4ERK5_ODOSH) with amino acid sequence
SLLGTVKDLLIGAGKSAAQSVLKGLSCKLSKDC. Experimentally determined and theoretical values (in parenthesis) for NIS and
NMD are given. (c) Box plots showing error distribution in the determination of monoisotopic and average mass (n = 104). (d) 3D
plot of peptide mass, NIS, and NMD of unreduced O. schmackeri. (e) 2D plot of NIS and NMD
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To further validate our approach, a peptide with a NMD of
0.49 and a NIS of 0.63, which had not been identified by the
database search, was chosen for further primary structure elu-
cidation. This was achieved through extended study of the
fragmentation spectra of different charge states of the peptide’s
precursor ion (see Figure 3 for the deconvoluted HCD frag-
mentation spectra of the peptide’s [M + 3H]3+ and [M + 4H]4+
ion). Interestingly, the two fragmentation spectra show relative-
ly large differences in the pattern and degree of fragmentation.
In the highmass-over-charge range the tandemMS spectrum of
the 3+ ion shows a predominant series of b ions, whereas the
fragmentation spectrum of the 4+ precursor reveals more prev-
alent y-ions in this region. In addition, the 4+ spectrum
(Figure 3a) shows a relatively large degree of internal fragments
around m/z 500–800, which are not seen for the 3+ spectrum
(Figure 3b). Based on a combined analysis of both spectra a
complete amino acid sequence of TSRCYVGYRHK[I/L]VCS
is proposed, which was not possible from studying the individ-
ual fragmentation spectra. This underlines the difficulty of de
novo sequencing non-tryptic peptides. A BLAST search
against this sequence reveals a high sequence similarity of this
peptide with the antimicrobial peptide Odorranain-T2-HN1
with amino acid sequence TSRCYVGYRRKIVCS (UniProt
accession number: E7EKE4). The only difference between
the newly identified O. schmackeri peptide and the earlier
reported one from O. hainanensis is a histidine residue at
position 10, instead of an arginine. It is therefore not unlikely
that the newly discovered peptide has antimicrobial activity as
well. This illustrates that even in a well-studied species, our 3D
mass map screening approach helps to identify novel structures
of potentially bioactive peptides.
To explore the potential of our cysteine-containing peptide
discovery strategy even further, the same workflow was applied
to the skin secretion of Bombina variegata. From the skin of this
particular frog, several peptides have been characterized previ-
ously, including the large family of antimicrobial bombinins and
bombinin-like peptides [23, 24]. However, only a few frog skin
peptides with one or more internal disulfide bonds have been
described up till now (i.e., the insulin releasing peptides kinino-
gen 1 and 2 [25], prokineticin [26], and the trypsin and thrombin
inhibitor BSTI [27]. In Figure 4, the 3D and the 2Dmap of mass
versus NMD are shown for both the reduced and the unreduced
B. variegata sample. From this plot, several candidate peptides
with low NIS and high NMD values were selected for a targeted
MS2 analysis. Table 1 lists the results from this analysis, and
many of the sequenced peptides have high similarity with
kinogen 1 and 2 associated peptides. Also peptides with simi-
larity to prokineticin and BSTI were found, although complete
sequencing was not possible from the acquired spectra. Besides
the peptides listed above, several novel structures were found
and two of these will be discussed in more detail below.
Example I
One of the most peculiar examples is the peptide that has an
apparent mass of 7163.273 Da (unreduced sample). This mass
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Figure 3. HCD fragmentation spectra of (a) [M + 4H]4+ at m/z 443.724 and (b) of the [M + 3H]3+ at m/z 591.297 of peptide
TSRCYVGYRHK(I/L)VCS from O. schmackeri skin secretion
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does not appear on themassmaps after reducing all the disulfide
bonds in the sample. Consistently, two novel peptides with
masses of 4983.389 and 2187.956 Da appeared in the reduced
sample, both of them not present in the unreduced sample. The
mass difference between single unreduced peptide and the two
reduced (complementary) peptides is 8.071 Da, which corre-
sponds to the mass increase upon reduction of four disulfide
bonds. The HCD fragmentation spectrum of the large
unreduced peptide (Figure 5a) shows a relatively low degree
of fragmentation. From the fragmentation spectrum of the re-
duced peptide with molecular weight of 4983.389 Da
(Figure 5b), a near complete sequence assignment could be
made (except for distinction between isoleucine and leucine).
From the fragmentation spectrum of the reduced peptide with
molecular weight of 2187.956 Da (Figure 5c), a near complete
sequence assignment could be made with only the 4–6N-termi-
nal residues unknown. More importantly, several of the se-
quence ions observed for this reduced peptide are identical to
fragment ions seen in the fragmentation spectrum of the large
unreduced peptide (inset of Figure 5a), confirming the
unreduced peptide is a dimeric peptide of the two reduced
peptides. Also, the number of identified cysteine residues (eight
in total) confirms the expected presence of four disulfide bonds.
The carboxy-terminal end of the small peptide has strong
similarity with the consensus sequence CCXXXXCN of
3-finger toxins, found in snake α-neurotoxins and frog cyto-
toxins [31, 32]. BLAST analysis of the two sequences against
the NCBI nonredundant protein database shows highest se-
quence similarity to the secreted Ly-6/uPAR-related protein-
1-like from Xenopus tropicalis (NCBI accession number:
XP_002939220.1). For the larger chain, fragmentation at the
last four C-terminal residues was not complete (Figure 5b).
Based on the high similarity with the X. tropicalis sequence, a
sequence assignment for the last four residues can be proposed.
Figure 5d shows the sequences of the two Bombina variegata
peptides and the Ly-6/uPar-related peptide and the xenoxins,
cytotoxins identified from the dorsal gland secretions of
Xenopus laevis. Besides identical positions for all the cysteines,
the sequences of B variegata and X. tropicalis show several











































































Figure 4. 3D mass mapping results of unreduced and reduced skin secretion of Bombina variegata. Shown are 3D plot of mass,
NMD, and NIS of (a) unreduced and (b) reduced peptides, and 2D plot of mass versus NMD of (c) unreduced and (d) reduced
peptides
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originates from DNA sequencing and evidence at protein level
or function is not known yet. The similarity with the xenoxins
previously shown to be present in the skin secretion of X. laevis
[33, 34] is much lower (Figure 5d). Interestingly, the prototype
and other described members of this family of 3-finger toxin
proteins are all known to be composed of a single polypeptide
chain. Remarkably the B. variegata variant discovered here is
composed of two chains, forming an intermolecular S–S-linked
heterodimer. Most likely this heterodimer is synthesized by
processing of a single polypeptide chain. Reanalysis of the
MS and MS2 data did not show evidence for the presence of
this full length single polypeptide and it also did not yield in the
detection of other heterodimeric forms of this peptide, suggest-
ing that the observed heterodimer is specifically formed and not
the result of specific degradation.
Example II
We discovered two more novel heterodimeric B. variegata
peptides (with masses of 3469.924 and 3541.942 Da). The
sequences of these two homologous dimeric peptides are, re-
spectively, (LQSLHKLRWPGKPLLLCENENGKLRPLamide-
CLS and LQSLHKLRWPGKPLLLCENENEKLRPLamide-
CLS) (Table 1). The sequences are given with all leucines, but
distinction between isoleucine and leucine could not be made.
Figure 6 shows the fragmentation spectra of the reduced and
unreduced form of the peptide with mass 3469.924 Da. The
spectra for the peptide with mass 3541.942 Da are given in
Supplementary Figure 2. Both dimeric peptides consist of a
chain with 27 amino acids, which is amidated at the C-
terminal residue. They only differ from each other with either
a glutamic acid or glycine at position 22. By analysis of the
HCD fragmentation spectra of the charge states 4+ to 6+, a
complete sequence assignment could be made (except the I/L
distinguishing) and Figure 6a shows the HCD fragmentation
spectrum with a, b, and y ion annotation of the 5+ charge state.
The other chain of both heterodimers is identical for both and
consists of only three amino acids. This chain was not recovered
in the analysis of the reduced sample, but the fragmentation
spectra of both unreduced dimers evidently showed that in the
small chain the Cys is the N-terminal amino acid flanked by an
Ile/Leu and Ser at the C-terminus (Figure 6b and Supplementary
Figure 2B). This was deduced from the loss of three single
amino acids from the precursor ion, which included the C-
terminal amidated Ile/Leu of the large chain, and the losses of
a C-terminal Ser. In the low m/z region, in the reduced peptide,
internal fragments corresponding to CysGlu and (ILe/Leu)Cys
were observed, whch were not observed for the unreduced
peptide. Simultaneously, for the unreduced dimeric peptide, a
y2 ion at m/z 219.134 was observed, corresponding to the two
C-terminal amino acids, (Ile/Leu)Ser of the small chain. The
two latter observations prove that both peptides are indeed a
disulfide bond-linked dimeric peptide. BLAST analysis against
anura sequences in the NCBInr database showed no significant
similarity with any other known frog skin peptide, indicating






























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Bombina variegata peptides LKCNTLEGRGVQATLCPPGKETCMTHSVLLNGNTNLMKGCATFSRCS xxxxxSHSESLYCCNLNLCN
XP_002939220.1 LKCNTLTEGRKEVTECPPGQTLCMTHSLTNNNKTDLTKGCTTFGRCARRDVFLYESEKLYCCNLDLCN
Xenoxin-1 (XEN1_XENLA)    LKCVNLQANGIKMTQECAKEDTKCLTLRSLKKTLKFCASGRTCTTMKIMSLPGEQITCCEGNMCNA
Xenoxin-2 (XEN2_XENLA)    LKCVNLQANGIKMTQECAKEDNKCLTLRSLKKTLKFCASDRICKTMKIMSLPGEKITCCEGNMCNA

































X X X X S H S E S L Y C C N L N L C N
y4 y3 y1




























































































































Figure 5. (a) HCD fragmentation spectra of [M + 7H]7+ at m/z 1024.332 of unreduced B. variegata peptide of monoisotopic mass
7163.273 Da. Inset shows short series of sequence ions. (b) HCD fragmentation spectrum of [M + 6H]6+ atm/z 831.572 of reduced
B. variegata peptide of monoisotopic mass 4983.389 Da. (c) HCD fragmentation spectrum of [M + 3H]3+ atm/z 730.326 of reduced
B. variegata peptide with monoisotopic mass of 2187.956. (d) Sequences of the B. variegata peptides, secreted Ly-6/uPAR-related
protein 1-like from X. tropicalis (NCBI refseq: XP_002939220.1), and 3 xenoxins from skin secretion of X. laevis, with obvious
similarities
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Conclusions
The normalized nominal mass defect and normalized isotope
shift of peptides containing cysteine residues renders them a
specific spatial distribution in 2D and 3D mass maps. We
developed a MATLAB script to compute both values from
experimentally obtained high resolution (orbitrap) mass spec-
trometry data. Together with 3D and 2D mass mapping, the
script considerably enhances the efficiency with which disulfide
bridge containing peptides can be detected in complex biological

































































































L Q S L H K L R W P G K P L L L C E N E N G K L R P L -amide
y26
b2


























































L Q S L H K L R W P G K P L L L C E N E N G K L R P L -amide





































400 600 800 1000 1200 1400 1600 1800 2000 2200 2400 2600 2800 3000 3200 3400
Figure 6. HCD fragmentation spectra of heterodimeric disulfide bond linked peptide from B. variegata with molecular mass of
3469.924 Da. (a) Deconvoluted HCD spectrum of the large reduced chain, ([M + 6H]6+ at m/z 526.141 (monoisotopic peak) was
selected for fragmentation). (b) Deconvoluted HCD spectrum of unreduced dimeric peptide, ([M + 6H]6+ at m/z 579.329 (monoiso-
topic peak) was selected for fragmentation. Insets highlight the loss of 1 N-terminal and 2 C-terminal residues
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considered as a tool to discover peptides that require this structural
element for biological activity and stability. After illustrating the
concept by analyzing a subset of the UniProt database
representing a collection of animal toxin sequences, we validated
our approach experimentally on the skin secretion of two frog
species. One of these species (O. schmackeri) is known to contain
many such S–S linked peptides; the other (B. variegata) is much
less studied in this respect. The workflow we elaborated indeed
selects previously reported peptides with intramolecular S–S
bonds. In addition, from B. variegata skin secretion novel intra-
and inter-molecular disulfide bridge-forming peptides were dis-
covered, confirming the usefulness of this novel approach.
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